LOGIN
Smoked cannabis effective in pain and hyperanalgesia modulation in HIV-SN patients
October 2018
Smoked cannabis effective in pain and hyperanalgesia modulation in HIV-SN patients
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:N/A
Cannabis in painful HIV-associated sensory neuropathy: a randomized placebo-controlled trial
Neurology. 2007;(7):515-21.Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
55 patients with HIV-associated sensory neuropathy (HIV-SN) were randomly assigned to receive either one 0.9g cigarette (3.56% delta-9-tetrahydrocannabinol) per day for 5 days, or its respective placebo with the identical schedule. Patients were assessed on pain on Visual Analogue Scale (VAS), hyperanalgesia, pain to heat stimulation, and incidence and severity of adverse events daily for 12 days....
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
The OE High Impact metric uses AI to determine the impact a study will have by considering the content of the article itself. Built using the latest advances of natural language processing techniques. OE High Impact predicts an article’s future number of citations than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.